403 related articles for article (PubMed ID: 27128492)
1. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?
Lozano ÓM; Rojas AJ; Fernández Calderón F
J Ment Health; 2017 Apr; 26(2):119-126. PubMed ID: 27128492
[TBL] [Abstract][Full Text] [Related]
2. Impact of addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug- and dual-dependent persons in residential treatment.
Colpaert K; De Maeyer J; Broekaert E; Vanderplasschen W
Eur Addict Res; 2013; 19(4):173-83. PubMed ID: 23257413
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders.
Chahua M; Sánchez-Niubò A; Torrens M; Sordo L; Bravo MJ; Brugal MT; Domingo-Salvany A;
Qual Life Res; 2015 Sep; 24(9):2129-37. PubMed ID: 25682367
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric comorbidity, psychological distress, and quality of life in gamma-hydroxybutyrate-dependent patients.
Kamal RM; Dijkstra BA; de Weert-van Oene GH; van Duren JA; de Jong CA
J Addict Dis; 2017; 36(1):72-79. PubMed ID: 27449738
[TBL] [Abstract][Full Text] [Related]
5. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
6. Substance use disorders in individuals with body dysmorphic disorder.
Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
[TBL] [Abstract][Full Text] [Related]
7. [Comorbidity in 207 cannabis users in a specific outpatient setting].
Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
[TBL] [Abstract][Full Text] [Related]
8. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
Havassy BE; Arns PG
Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
[TBL] [Abstract][Full Text] [Related]
9. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
[TBL] [Abstract][Full Text] [Related]
10. Severity factors associated with borderline personality disorder among misusers in an outpatient sample in Spain.
Barral C; Daigre C; Bachiller D; Calvo N; Ros-Cucurull E; Gancedo B; Grau-López L; Ferrer M; Casas M; Roncero C
J Addict Dis; 2017; 36(2):93-96. PubMed ID: 28001490
[TBL] [Abstract][Full Text] [Related]
11. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
Shrier LA; Harris SK; Kurland M; Knight JR
Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
[TBL] [Abstract][Full Text] [Related]
13. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment.
Astals M; Domingo-Salvany A; Buenaventura CC; Tato J; Vazquez JM; Martín-Santos R; Torrens M
Subst Use Misuse; 2008; 43(5):612-32. PubMed ID: 18393080
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients.
Carpentier PJ; Krabbe PF; van Gogh MT; Knapen LJ; Buitelaar JK; de Jong CA
Am J Addict; 2009; 18(6):470-80. PubMed ID: 19874168
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Hasin DS; Stinson FS; Ogburn E; Grant BF
Arch Gen Psychiatry; 2007 Jul; 64(7):830-42. PubMed ID: 17606817
[TBL] [Abstract][Full Text] [Related]
17. The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity.
Calsyn DA; Saxon AJ; Bush KR; Howell DN; Baer JS; Sloan KL; Malte CA; Kivlahan DR
Drug Alcohol Depend; 2004 Nov; 76(2):165-71. PubMed ID: 15488340
[TBL] [Abstract][Full Text] [Related]
18. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
[TBL] [Abstract][Full Text] [Related]
20. Association between severity of illicit drug dependence and quality of life in a psychosocial care center in BRAZIL: cross-sectional study.
Campêlo SR; Barbosa MA; Dias DR; Caixeta CC; Leles CR; Porto CC
Health Qual Life Outcomes; 2017 Nov; 15(1):223. PubMed ID: 29149893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
